Suppr超能文献

相似文献

2
Use of Expression Profiles of HBV-DNA Integrated Into Genomes of Hepatocellular Carcinoma Cells to Select T Cells for Immunotherapy.
Gastroenterology. 2019 May;156(6):1862-1876.e9. doi: 10.1053/j.gastro.2019.01.251. Epub 2019 Jan 31.
6
Immune repertoire: A potential biomarker and therapeutic for hepatocellular carcinoma.
Cancer Lett. 2016 Sep 1;379(2):206-12. doi: 10.1016/j.canlet.2015.06.022. Epub 2015 Jul 15.
7
T Cell-Associated Immunotherapy for Hepatocellular Carcinoma.
Cell Physiol Biochem. 2017;41(2):609-622. doi: 10.1159/000457883. Epub 2017 Feb 3.
8
Defining virus-specific CD8+ TCR repertoires for therapeutic regeneration of T cells against chronic hepatitis E.
J Hepatol. 2019 Oct;71(4):673-684. doi: 10.1016/j.jhep.2019.06.005. Epub 2019 Jun 14.
10
TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumors.
Cancer Immunol Immunother. 2016 Mar;65(3):293-304. doi: 10.1007/s00262-016-1800-2. Epub 2016 Feb 3.

引用本文的文献

1
The pathogenesis of liver cancer and the therapeutic potential of bioactive substances.
Front Pharmacol. 2022 Oct 5;13:1029601. doi: 10.3389/fphar.2022.1029601. eCollection 2022.
2
Human MAIT cells endowed with HBV specificity are cytotoxic and migrate towards HBV-HCC while retaining antimicrobial functions.
JHEP Rep. 2021 Jun 11;3(4):100318. doi: 10.1016/j.jhepr.2021.100318. eCollection 2021 Aug.
3
T Cell Repertoire During Ontogeny and Characteristics in Inflammatory Disorders in Adults and Childhood.
Front Immunol. 2021 Feb 9;11:611573. doi: 10.3389/fimmu.2020.611573. eCollection 2020.
4
TCR Gene Therapy: Challenges, Opportunities, and Future Directions.
Cells. 2020 Dec 1;9(12):2567. doi: 10.3390/cells9122567.

本文引用的文献

1
The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis.
J Hepatol. 2020 Sep;73(3):523-532. doi: 10.1016/j.jhep.2020.04.008. Epub 2020 Apr 23.
2
Challenges of CAR- and TCR-T cell-based therapy for chronic infections.
J Exp Med. 2020 May 4;217(5). doi: 10.1084/jem.20191663.
3
Immune-based therapies for hepatocellular carcinoma.
Oncogene. 2020 Apr;39(18):3620-3637. doi: 10.1038/s41388-020-1249-9. Epub 2020 Mar 10.
4
MAIT Cells Come to the Rescue in Cancer Immunotherapy?
Cancers (Basel). 2020 Feb 11;12(2):413. doi: 10.3390/cancers12020413.
5
Functions of human liver CD69CD103CD8 T cells depend on HIF-2α activity in healthy and pathologic livers.
J Hepatol. 2020 Jun;72(6):1170-1181. doi: 10.1016/j.jhep.2020.01.010. Epub 2020 Jan 24.
6
Next-Generation Liver Medicine Using Organoid Models.
Front Cell Dev Biol. 2019 Dec 20;7:345. doi: 10.3389/fcell.2019.00345. eCollection 2019.
7
A class of γδ T cell receptors recognize the underside of the antigen-presenting molecule MR1.
Science. 2019 Dec 20;366(6472):1522-1527. doi: 10.1126/science.aav3900.
9
MAIT Cells Promote Tumor Initiation, Growth, and Metastases via Tumor MR1.
Cancer Discov. 2020 Jan;10(1):124-141. doi: 10.1158/2159-8290.CD-19-0569. Epub 2019 Dec 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验